FDA Approved: ARGATROBAN — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a generic Argatroban from Mylan Institutional LLC under ANDA 202626 for use as an anticoagulant in adults with heparin-induced thrombocytopenia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heparin-induced Thrombocytopenia

Drugs mentioned

• Argatroban (argatroban)

Snippet

ORIG AP for ARGATROBAN (ARGATROBAN)